Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study-Reference-Cited by-同舟云学术

Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study

Published:2014-07-17 Issue:11 Volume:21 Page:1353-e88
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Roshanisefat H.¹²³,Bahmanyar S.³,Hillert J.¹²,Olsson T.²,Montgomery S.³⁴⁵

Affiliation:

1. Department of Neurology; Karolinska University Hospital Huddinge; Stockholm Sweden

2. Neuroimmunology Unit; Centre for Molecular Medicine; Department of Clinical Neuroscience; Karolinska Institute and; Karolinska University Hospital; Solna Stockholm Sweden

3. Clinical Epidemiology Unit and; Centre for Pharmacoepidemiology; Department of Medicine; Karolinska Institute; Karolinska University Hospital; Stockholm Sweden

4. Clinical Epidemiology and Biostatistics; Örebro University Hospital and; Örebro University; Örebro Sweden

5. Department of Epidemiology and Public Health; University College London; London UK

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ene.12518/fullpdf

Reference43 articles.

1. High risk of cardiovascular diseases after diagnosis of multiple sclerosis;Jadidi;Mult Scler,2013

2. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study;Christiansen;Neuroepidemiology,2010

3. Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system;Aktas;Der Nervenarzt,2011